Prevention of Group B streptococcus infection research hub

A Randomised, Observer-Blind Trial to Evaluate the Immunogenicity, Safety, and Reactogenicity of a Group B Streptococcus Vaccine (GBS-NN/NN-2) when 1 Dose is Administered Concomitantly with the TDaP Vaccine in Healthy Non-pregnant Women 18 to 49 years of age Compared to when Each Vaccine is Administered Alone

This study is looking at a new vaccine to prevent Group B Strep infection in women aged 18 to 49. It checks how well the vaccine works and if it's safe when given with a routine tetanus, diphtheria, and whooping cough jab, or if given alone.